Inactivating mutations in <i>BRCA1-associated protein 1</i> (<i>BAP1</i>) are observed in approximately 45% of primary and ~85% of metastatic uveal melanoma (UM) cases and are strongly correlated with aggressive phenotypes and poor prognosis. The gene discussed is BAP1; the disease is uveal melanoma.